These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 17108864

  • 1. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.
    Colecchia A, Vestito A, La Rocca A, Pasqui F, Nikiforaki A, Festi D, Symbiotic Study Group.
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):349-58. PubMed ID: 17108864
    [Abstract] [Full Text] [Related]

  • 2. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
    Dughera L, Elia C, Navino M, Cisarò F, ARMONIA Study Group.
    Acta Biomed; 2007 Aug; 78(2):111-6. PubMed ID: 17933278
    [Abstract] [Full Text] [Related]

  • 3. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 4. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M, Pellicano R, Terzi E, Simondi D, Rizzetto M.
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [Abstract] [Full Text] [Related]

  • 5. Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome.
    Tsuchiya J, Barreto R, Okura R, Kawakita S, Fesce E, Marotta F.
    Chin J Dig Dis; 2004 Dec; 5(4):169-74. PubMed ID: 15612887
    [Abstract] [Full Text] [Related]

  • 6. Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight).
    Amenta M, Cascio MT, Di Fiore P, Venturini I.
    Acta Biomed; 2006 Dec; 77(3):157-62. PubMed ID: 17312986
    [Abstract] [Full Text] [Related]

  • 7. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC, Croffut RM, Stranahan MC.
    Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
    [Abstract] [Full Text] [Related]

  • 8. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
    Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, Matuchansky C.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):475-86. PubMed ID: 17635382
    [Abstract] [Full Text] [Related]

  • 9. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
    Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD.
    Am J Gastroenterol; 2003 Nov 01; 98(11):2454-9. PubMed ID: 14638348
    [Abstract] [Full Text] [Related]

  • 10. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.
    Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR.
    Aliment Pharmacol Ther; 2009 Mar 01; 29(5):508-18. PubMed ID: 19053980
    [Abstract] [Full Text] [Related]

  • 11. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R.
    Aliment Pharmacol Ther; 2008 Aug 15; 28(4):385-96. PubMed ID: 18532993
    [Abstract] [Full Text] [Related]

  • 12. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study.
    Andriulli A, Neri M, Loguercio C, Terreni N, Merla A, Cardarella MP, Federico A, Chilovi F, Milandri GL, De Bona M, Cavenati S, Gullini S, Abbiati R, Garbagna N, Cerutti R, Grossi E.
    J Clin Gastroenterol; 2008 Sep 15; 42 Suppl 3 Pt 2():S218-23. PubMed ID: 18685503
    [Abstract] [Full Text] [Related]

  • 13. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study.
    Bekkali NL, Bongers ME, Van den Berg MM, Liem O, Benninga MA.
    Nutr J; 2007 Aug 04; 6():17. PubMed ID: 17683583
    [Abstract] [Full Text] [Related]

  • 14. Probiotics and functional gastrointestinal disorders in children.
    Vandenplas Y, Benninga M.
    J Pediatr Gastroenterol Nutr; 2009 Apr 04; 48 Suppl 2():S107-9. PubMed ID: 19300120
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
    Plassmann D, Schulte-Witte H.
    Med Klin (Munich); 2007 Nov 15; 102(11):888-92. PubMed ID: 17992479
    [Abstract] [Full Text] [Related]

  • 16. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R.
    J Clin Gastroenterol; 2008 Sep 15; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [Abstract] [Full Text] [Related]

  • 17. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ.
    Gastroenterology; 2006 Oct 15; 131(4):1003-10. PubMed ID: 17030170
    [Abstract] [Full Text] [Related]

  • 18. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S, Mora D, Gschwender M, Popp K.
    Aliment Pharmacol Ther; 2011 May 15; 33(10):1123-32. PubMed ID: 21418261
    [Abstract] [Full Text] [Related]

  • 19. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
    Hun L.
    Postgrad Med; 2009 Mar 15; 121(2):119-24. PubMed ID: 19332970
    [Abstract] [Full Text] [Related]

  • 20. Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: an open-label, partially controlled, 1-year extension of a previously published controlled clinical trial.
    Bittner AC, Croffut RM, Stranahan MC, Yokelson TN.
    Clin Ther; 2007 Jun 15; 29(6):1153-60. PubMed ID: 17692729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.